Latest News

There are few similarities between reimbursement decision-making in Australia and New Zealand but they share a disconnect between public presentation and day-to-day reality.

New GSK boss Patrick Desbiens told BioPharmaDispatch he looks forward to supporting and contributing to the industry's busy work program in Australia.

According to Bloomberg, the number of COVID-19 vaccines administered globally is 8.09 billion across 184 countries. The latest daily rate of doses administered is 37.1 million. COVAX has so far shipped over 589 million doses of COVID-19 vaccines to 144 participants.

Organon's Luke Cornish said it is more important than ever for companies to have a "seat at the policy table" and that these conversations need to be held in the appropriate place.

GBMA chair Jane Halton AO PSM said she is proud to lead a growing membership base with a board comprised of some of the most experienced health executives in the country.

New Zealand has agreed to procure 60,000 doses of Pfizer's COVID-19 oral antiviral candidate, PF-07321332, subject to approval by the country's regulator.

"While countries like Japan, Germany, Austria and Great Britain get around 60% of their new medicines reimbursed within three months of registration, Australia only manages to get 2% reimbursed within three months," says the new report commissioned by Johnson & Johnson.

Janssen's Biljana Naumovic and Susan Martin of Johnson & Johnson Medical spoke with BioPharmaDispatch about the new report prepared by Dr Brendan Shaw of Shawview Consulting.

We are constantly lectured about these frameworks being the best in the world. Yet, obviously not, given to this day they are still considered incapable of dealing with the most important therapeutic interventions in living memory.

The Juvenile Arthritis Foundation Australia has welcomed the new parliamentary inquiry into juvenile arthritis and other childhood rheumatic diseases.

The TGA has provisionally approved Pfizer's COVID-19 vaccine COMIRNATY for 5 to 11-year-olds. Health minister Greg Hunt said it will now be rolled out from 10 January 2022 subject to advice from the Australian Technical Advisory Group on Immunisation. 

"The PBAC now has more information and data to support these two applications than any other country has requested," said the company in a statement.